Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lenograstim × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 1083 Specimen Handling 723 Carboplatin 710 Cyclophosphamide 698 Magnetic Resonance Spectroscopy 678 Cisplatin 611 Nivolumab 590 Paclitaxel 536 Radiotherapy 482 Gemcitabine 471 Biopsy 441 Bevacizumab 399 Dexamethasone 388 fludarabine 346 Docetaxel 338 venetoclax 334 Oxaliplatin 315 atezolizumab 313 Capecitabine 312 Fluorouracil 310 Rituximab 301 durvalumab 288 Doxorubicin 269 Radiosurgery 269 Ipilimumab 263 Pemetrexed 263 Drug Therapy 262 Standard of Care 253 Radiation 248 Lenalidomide 246

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡